Timothy R.M. Bryant General Counsel
Timothy R.M. Bryant is the General Counsel of HCRx. Mr. Bryant is responsible for all of HCRx’s legal matters. He brings over 35 years of experience in private and public investing, having first represented biopharmaceutical royalty investors in 2001. Mr. Bryant was previously a Partner and the General Counsel of Adams Street Partners, the global private equity firm, and prior to that a Partner at McDermott Will & Emery. Mr. Bryant currently serves as a member of the Board of Directors of Valinor Pharmaceuticals. Mr. Bryant holds a B.A., M.A., and J.D., all from Northwestern University.